+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

COVID-19 Drug Delivery Devices - Global Market Outlook (2019-2027)

  • ID: 5221414
  • Report
  • November 2020
  • Region: Global
  • 150 pages
  • Stratistics Market Research Consulting Pvt Ltd

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AstraZeneca
  • Bharat Biotech
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Moderna
  • Novawax Inc
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

According to the report, the Global COVID-19 Drug Delivery Devices market accounted for $2.07 billion in 2019 and is expected to reach $4.47 billion by 2027 growing at a CAGR of 10.1% during the forecast period. Competitive race among the healthcare companies and drastic surge in drug development due to the COVID-19 outbreak are the major factors driving the market growth. However, high manufacturing cost of COVID-19 drug delivery devices is restraining the market growth.



COVID-19 Drug Delivery Devices are engineered technologies for efficient drug delivery and/or release of therapeutic agents in the circulatory system and drug movement through cells and tissues for the prevention of COVID-19. Drug delivery devices control the rate at which a drug is released and the location in the body where it is released. Some systems can control both the tasks.

Based on route of administration, the parenteral segment is likely to have a huge demand. Novel biologics such as RNA and DNA-based vaccines, recombinant nano particles, and monoclonal antibodies are currently being explored in clinical trials. Such biologics can only be administered intravenously as they are degraded when given orally. Currently, about 10 potential COVID-19 vaccine candidates have entered the clinical trials, most of which are to be administered via a parenteral route of administration.

By geography, North America is going to have a lucrative growth during the forecast period. North America has a well-established healthcare infrastructure and a large number of key pharmaceutical companies. It is a developed economy with high disposable income, which enables people to choose from various advanced treatment options. In the U.S., a collaborative framework was established by an initiative named Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV).

Some of the key players profiled in the COVID-19 Drug Delivery Devices Market include AstraZeneca, Bharat Biotech, GlaxoSmithKline Plc, Johnson & Johnson, Moderna, Novawax Inc, Pfizer, PharmaJet and Serum Institute of India.

Route of Administrations Covered:
  • Dermal
  • Nasal
  • Parenteral
Distribution Channels Covered:
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Products Covered:
  • Inhalers
  • Needle Free Injectors
  • Patches
  • Prefilled Syringe
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What the Report offers:
  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Free Customization Offerings:

Purchasers of this report will be entitled to receive one of the following free customization options:
  • Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca
  • Bharat Biotech
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Moderna
  • Novawax Inc
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global COVID-19 Drug Delivery Devices Market, By Route of Administration
5.1 Introduction
5.2 Dermal
5.3 Nasal
5.4 Parenteral

6 Global COVID-19 Drug Delivery Devices Market, By Distribution Channel
6.1 Introduction
6.2 Retail Pharmacies
6.3 Online Pharmacies
6.4 Hospital Pharmacies

7 Global COVID-19 Drug Delivery Devices Market, By Product
7.1 Introduction
7.2 Inhalers
7.3 Needle Free Injectors
7.4 Patches
7.5 Prefilled Syringe

8 Global COVID-19 Drug Delivery Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 AstraZeneca
10.2 Bharat Biotech
10.3 GlaxoSmithKline Plc
10.4 Johnson & Johnson
10.5 Moderna
10.6 Novawax Inc
10.7 Pfizer
10.8 PharmaJet
10.9 Serum Institute of India

List of Tables
Table 1 Global COVID-19 Drug Delivery Devices Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 3 Global COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
Table 4 Global COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
Table 5 Global COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
Table 6 Global COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 7 Global COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
Table 8 Global COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 9 Global COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 10 Global COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
Table 11 Global COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
Table 12 Global COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
Table 13 Global COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
Table 14 Global COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
Table 15 North America COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
Table 16 North America COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 17 North America COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
Table 18 North America COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
Table 19 North America COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
Table 20 North America COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 21 North America COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
Table 22 North America COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 23 North America COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 24 North America COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
Table 25 North America COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
Table 26 North America COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
Table 27 North America COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
Table 28 North America COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
Table 29 Europe COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
Table 30 Europe COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 31 Europe COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
Table 32 Europe COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
Table 33 Europe COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
Table 34 Europe COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 35 Europe COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
Table 36 Europe COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 37 Europe COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 38 Europe COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
Table 39 Europe COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
Table 40 Europe COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
Table 41 Europe COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
Table 42 Europe COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
Table 43 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
Table 44 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 45 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
Table 46 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
Table 47 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
Table 48 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 49 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
Table 50 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 51 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 52 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
Table 53 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
Table 54 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
Table 55 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
Table 56 Asia Pacific COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
Table 57 South America COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
Table 58 South America COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 59 South America COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
Table 60 South America COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
Table 61 South America COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
Table 62 South America COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 63 South America COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
Table 64 South America COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 65 South America COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 66 South America COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
Table 67 South America COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
Table 68 South America COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
Table 69 South America COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
Table 70 South America COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)
Table 71 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Country (2018-2027) ($MN)
Table 72 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 73 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Dermal (2018-2027) ($MN)
Table 74 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Nasal (2018-2027) ($MN)
Table 75 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Parenteral (2018-2027) ($MN)
Table 76 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 77 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
Table 78 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 79 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 80 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Product (2018-2027) ($MN)
Table 81 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Inhalers (2018-2027) ($MN)
Table 82 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Needle Free Injectors (2018-2027) ($MN)
Table 83 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Patches (2018-2027) ($MN)
Table 84 Middle East & Africa COVID-19 Drug Delivery Devices Market Outlook, By Prefilled Syringe (2018-2027) ($MN)


Note: Product cover images may vary from those shown
  • AstraZeneca
  • Bharat Biotech
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Moderna
  • Novawax Inc
  • Pfizer
  • PharmaJet
  • Serum Institute of India
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll